Organization · Venture Capital
LifeSci Venture Partners
LifeSci Venture Partners is a New York-based healthcare-focused venture capital firm that specializes in early-to-late stage investments in clinical-stage biopharmaceutical and life sciences companies. The firm leverages its integrated access to public markets to support portfolio companies.
Overview
What LifeSci Venture Partners does
What LifeSci Venture Partners is
LifeSci Venture Partners is a New York-based healthcare-focused venture capital firm that specializes in early-to-late stage investments in clinical-stage biopharmaceutical and life sciences companies. The firm leverages its integrated access to public markets to support portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find LifeSci Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
LifeSci Venture Partners as a funder
Investment thesis
LifeSci Venture Partners focuses on transformational clinical-stage biopharmaceutical companies with proof-of-concept data, targeting those expected to go public within 12–18 months of investment. The firm's integration with LifeSci Capital and LifeSci Advisors provides a differentiated pathway for portfolio companies to access public markets.
Focus narrative
The firm primarily invests in clinical-stage opportunities that have achieved proof-of-concept and are planning to transition to the public market within 12-18 months. LifeSci Venture Partners targets companies that are innovating in molecular medicine, technology, or healthcare delivery, with a strong emphasis on transformational biopharmaceutical advancements.
Value beyond capital
LifeSci Venture Partners adds value to its portfolio companies through its deep expertise in the biopharmaceutical sector, providing strategic guidance and support in navigating the complexities of clinical development and public market transitions. The firm's connections within the LifeSci ecosystem facilitate access to investor relations and capital markets, enhancing the growth potential of its investments.
Terms and economics
- Typical check
- $64,800,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series D · Growth Equity
- Regions
- North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Erasca, Caribou Biosciences, and Science 37
Portfolio context
Notable portfolio companies include: Century Therapeutics (IPSC): Developing cell therapies for cancer. Yarrow Biosciences (VYNE): Engaged in biopharmaceutical development. Minerva Neurosciences (NERV): Focused on treatments for central nervous system disorders. Veradermics (MANE): Developing therapies for hair loss. Candid Therapeutics: Specializes in autoimmune therapies. Erasca: Creating new oncology treatments. Cala Health: A bioelectronic medicine company. Beta Bionics: Developing a medical device for diabetes management. Akero: Focused on serious metabolic diseases. Engage Therapeutics: Developing a drug-device combination for seizure management.
Common questions
What to know about LifeSci Venture Partners
Upseed classifies LifeSci Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.